Journal
NPJ GENOMIC MEDICINE
Volume 7, Issue 1, Pages -Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41525-022-00323-y
Keywords
-
Categories
Ask authors/readers for more resources
The combination of DNA and RNA sequencing can help overcome the challenges in identifying and interpreting splicing variants for individuals with hereditary cancer predisposition, providing mutational and splicing landscape information for clinical cohorts.
DNA germline genetic testing can identify individuals with cancer susceptibility. However, DNA sequencing alone is limited in its detection and classification of mRNA splicing variants, particularly those located far from coding sequences. Here we address the limitations of splicing variant identification and interpretation by pairing DNA and RNA sequencing and describe the mutational and splicing landscape in a clinical cohort of 43,524 individuals undergoing genetic testing for hereditary cancer predisposition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available